THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTParallax Health Sciences, Inc. • June 22nd, 2018 • Retail-drug stores and proprietary stores • California
PARALLAX HEALTH SCIENCES, INC., a Nevada corporation (the “Company”), for value received, hereby certifies that __________________________________, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 6:00 p.m. PST on June 18, 2021, 6,000,000 shares (subject to adjustment as set forth herein) of Common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of US$.25 per share (subject to adjustment as set forth herein). The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
NOTE AND PURCHASE AGREEMENTNote and Purchase Agreement • June 22nd, 2018 • Parallax Health Sciences, Inc. • Retail-drug stores and proprietary stores • California
This Note and Purchase Agreement (this “Agreement”) is dated as of June 18, 2018 among PARALLAX HEALTH SCIENCES, INC., a Nevada corporation with its principal place of business located at 1327 Ocean Avenue, Suite B, Santa Monica CA 90401 (the “Company”), and ________________________________________ with an address at __________________________________________ and the other purchasers, if any, identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • June 22nd, 2018 • Parallax Health Sciences, Inc. • Retail-drug stores and proprietary stores • California
PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 18, 2018, by and between Parallax Health Sciences, Inc., a Nevada corporation (the “Company”), and ______________________________, (the “Holder”).
SECURITY AGREEMENTSecurity Agreement • June 22nd, 2018 • Parallax Health Sciences, Inc. • Retail-drug stores and proprietary stores • California
This Security Agreement (“Agreement”) is made and entered into as of June 18, 2018, by and between PARALLAX HEALTH SCIENCES, INC., a Nevada corporation with its principal place of business located at 1327 Ocean Avenue Suite B, Santa Monica CA 90401 (the “Debtor”), and _______________________________________________________ with an address at ______________________________________ and the other purchasers, if any, identified on the signature pages to the Purchase Agreement (each, including its successors and assigns, a “Secured Party” and collectively the “Secured Parties”).
AMENDMENT TO WARRANT AGREEMENTWarrant Agreement • June 22nd, 2018 • Parallax Health Sciences, Inc. • Retail-drug stores and proprietary stores
THIS FIRST AMENDMENT TO THE WARRANT AGREEMENT dated June __, 2018, by and between Parallax Health Sciences, Inc., a Nevada corporation, with its principal office at 1327 Ocean Ave., Suite M, Santa Monica, CA 90401, (the “Company”) and _________________________, (the “Registered Holder”) is hereby amended as follows with the remaining provisions of the Warrant Agreement remaining in full force and effect.
AMENDMENT TO CONVERTIBLE NOTE PURCHASE AGREEMENT AND NOTE PARALLAX HEALTH SCIENCES, INC.Convertible Note Purchase Agreement and Note • June 22nd, 2018 • Parallax Health Sciences, Inc. • Retail-drug stores and proprietary stores
THIS FIRST AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT AND NOTE (the “Amendment”) is executed as of this __ day of June, 2018 (the “Effective Date”) by and between Parallax Health Sciences, Inc., a Nevada corporation, with its principal office at 1327 Ocean Ave., Suite M, Santa Monica, CA 90401, (the “Company”) and _________________________, (the “Purchaser”).
